REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Sellwell Pharmaceuticals Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Sellwell Pharmaceuticals Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Sellwell Pharmaceuticals Limited is an enterprise in India, with the main office in Indore. It operates in the Pharmaceutical and Medicine Manufacturing industry. Sellwell Pharmaceuticals Limited was incorporated on August 14, 1989. The company’s latest financial report indicates a net sales revenue drop of 21.26% in 2024. A negative growth of 7.46% was recorded in its total assets. In, 2024, the company’s net profit margin increased by 0.49%.

Headquarters
No. 92 Sector - E Sanwer Road Indore In-Mp In 452015
Indore; Madhya Pradesh; Postal Code: 452015

Contact Details: Purchase the Sellwell Pharmaceuticals Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Sellwell Pharmaceuticals Limited report to view the information.
Financial Auditors:
Purchase the Sellwell Pharmaceuticals Limited report to view the information.
Incorporation Date:
August 14, 1989
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
60.1%
Purchase this report to view the information.
39.81%
Company Performance
Financial values in the chart are available after Sellwell Pharmaceuticals Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-21.26%▼
Total Operating Revenue
-20.58%▼
Operating Profit
6.53%▲
EBITDA
5.45%▲
Net Profit/Loss for the Period
22.76%▲
Total Assets
-7.46%▼
Total Equity
8.78%▲
Operating Profit Margin
0.84%▲
Net Profit Margin
0.49%▲
Return on Equity (ROE)
0.92%▲
Debt / Equity
18.53%▲
Quick Ratio
0.05%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo